Literature DB >> 25126276

Methicillin-Resistant Staphylococcus aureus: A Growing Risk in the Hospital and in the Community.

Jose L Raygada1, Donald P Levine2.   

Abstract

Methicillin-resistant Staphylococcus aureus is a common and continuously growing cause of nosocomial and community-acquired infections. The type, disease severity, and clinical outcomes of these infections, as well as the genotypic and susceptibility patterns of the bacteria differ according to the setting in which the infection occurs-a healthcare facility or the community setting. The incidence of these infections in the community setting has been growing consistently in the past decade or so. In addition, resistance to the many current antibiotics used to treat these infections is also growing, further complicating management. Rapid-diagnosis tests and new therapeutic agents are constantly under investigation. The authors review the current understanding of the epidemiology, clinical manifestations, and management of methicillin-resistant Staphylococcus aureus infection, including the growing problem of resistance. In addition, they discuss promising diagnostic and therapeutic alternatives, as well as new control strategies to prevent its transmission or the development of infection among carriers.

Entities:  

Year:  2009        PMID: 25126276      PMCID: PMC4115307     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN: 1942-2962


  34 in total

Review 1.  Management of multidrug-resistant organisms in health care settings, 2006.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 2.  Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus.

Authors:  Binh An Diep; Steven R Gill; Richard F Chang; Tiffany HaiVan Phan; Jason H Chen; Matthew G Davidson; Felice Lin; Jessica Lin; Heather A Carleton; Emmanuel F Mongodin; George F Sensabaugh; Françoise Perdreau-Remington
Journal:  Lancet       Date:  2006-03-04       Impact factor: 79.321

3.  The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam.

Authors:  E J Ellis-Grosse; T Babinchak; N Dartois; G Rose; E Loh
Journal:  Clin Infect Dis       Date:  2005-09-01       Impact factor: 9.079

Review 4.  Prevention of Staphylococcus aureus infections: advances in vaccine development.

Authors:  Henry R Shinefield; Steven Black
Journal:  Expert Rev Vaccines       Date:  2005-10       Impact factor: 5.217

5.  High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia.

Authors:  M Sharma; K Riederer; P Chase; R Khatib
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-23       Impact factor: 3.267

6.  Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase.

Authors:  Cesar A Arias; Martha Vallejo; Jinnethe Reyes; Diana Panesso; Jaime Moreno; Elizabeth Castañeda; Maria V Villegas; Barbara E Murray; John P Quinn
Journal:  J Clin Microbiol       Date:  2008-01-03       Impact factor: 5.948

7.  Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database.

Authors:  Linda K McDougal; Christine D Steward; George E Killgore; Jasmine M Chaitram; Sigrid K McAllister; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

8.  Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection.

Authors:  N Markowitz; E L Quinn; L D Saravolatz
Journal:  Ann Intern Med       Date:  1992-09-01       Impact factor: 25.391

Review 9.  Vaccination and passive immunisation against Staphylococcus aureus.

Authors:  Adam C Schaffer; Jean C Lee
Journal:  Int J Antimicrob Agents       Date:  2008-08-30       Impact factor: 5.283

10.  Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season.

Authors:  Jeffrey C Hageman; Timothy M Uyeki; John S Francis; Daniel B Jernigan; J Gary Wheeler; Carolyn B Bridges; Stephen J Barenkamp; Dawn M Sievert; Arjun Srinivasan; Meg C Doherty; Linda K McDougal; George E Killgore; Uri A Lopatin; Rebecca Coffman; J Kathryn MacDonald; Sigrid K McAllister; Gregory E Fosheim; Jean B Patel; L Clifford McDonald
Journal:  Emerg Infect Dis       Date:  2006-06       Impact factor: 6.883

View more
  8 in total

1.  Healthcare-associated pneumonia: a prospective study in Spain.

Authors:  P Llinares; M C Fariñas; F Arnaíz de Las Revillas; D Sousa; C Ardunay; C García-Vidal; M Montejo; R Rodríguez-Álvarez; J Pasquau; E Bouza; J A Oteo; C Balseiro; C Méndez; N Lwoff
Journal:  Rev Esp Quimioter       Date:  2020-07-22       Impact factor: 1.553

2.  Investigating the relation between resistance pattern and type of Staphylococcal cassette chromosome mec (SCCmec) in methicillin-resistant Staphylococcus aureus.

Authors:  Christiana Rezk Bottros Youssef; Ashraf Ahmed Kadry; Amira Mohammed El-Ganiny
Journal:  Iran J Microbiol       Date:  2022-02

3.  Pathogens of peritoneal dialysis peritonitis: Trends from a single-center experience over 15 years.

Authors:  Tae Yeon Hwang; Myung Gyu Kim; Se Won Oh; Sang-Kyung Jo; Won-Yong Cho; Jihyun Yang
Journal:  Kidney Res Clin Pract       Date:  2020-06-30

4.  Staphylococcus aureus Infection in a Pediatric ICU: A Hospital Based Prospective Observational Study.

Authors:  Ishtiyaq Qadri; Ishaq Malik; Kaisar Ahmed
Journal:  Indian J Crit Care Med       Date:  2019-05

5.  The in vitro efficacy of eye drops containing a bacteriophage solution specific for Staphylococcus spp. isolated from dogs with bacterial conjunctivitis.

Authors:  Renata Urban-Chmiel; Ireneusz Balicki; Katarzyna Świąder; Anna Nowaczek; Ewelina Pyzik; Dagmara Stępień-Pyśniak; Agnieszka Marek; Andrzej Puchalski; Andrzej Wernicki; Ewa Poleszak; Marta Dec
Journal:  Ir Vet J       Date:  2020-11-04       Impact factor: 2.146

6.  Antibiofilm Activity of Azadirachta indica and Catharanthus roseus and Their Synergistic Effects in Combination with Antimicrobial Agents against Fluconazole-Resistant Candida albicans Strains and MRSA.

Authors:  David Neglo; Francisca Adzaho; Irene A Agbo; Richmond Arthur; Daniel Sedohia; Clement Okraku Tettey; Sayanika Devi Waikhom
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-21       Impact factor: 2.629

Review 7.  Application of bacteriocins in food preservation and infectious disease treatment for humans and livestock: a review.

Authors:  Zhang Jin Ng; Mazni Abu Zarin; Chee Keong Lee; Joo Shun Tan
Journal:  RSC Adv       Date:  2020-10-23       Impact factor: 4.036

8.  Prevalence of MDR organism (MDRO) carriage in children and their household members in Siem Reap Province, Cambodia.

Authors:  Shweta R Singh; Bunsoth Mao; Konstantin Evdokimov; Pisey Tan; Phana Leab; Rick Ong; Saphonn Vonthanak; Clarence C Tam; Li Yang Hsu; Paul Turner
Journal:  JAC Antimicrob Resist       Date:  2020-12-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.